What were the key takeaways from National Health's earnings call?

What is National Health's gross profit margin?

What guidance did National Health's management provide for the next earnings period?

What is National Health's latest dividend and current dividend yield?

What were the key takeaways from National Health’s earnings call?

What is the revenue and EPS growth rate for National Health year over year?

Did National Health beat or miss consensus estimates last quarter?

What is the market's earnings forecast for National Health next quarter?

- **SHOP Growth Acceleration**: 63% YoY NOI growth, 2026 target for 20%+ contribution, and $74.3M acquisition at 8.2% yield.
- **Guidance Upgrade**: 10%+ FFO growth, $75M new investments, and 3.6x debt/EBITDA.
- **NHC Lease Uncertainty**: Renewal legality under review; potential arbitration over fair market rent.
- **Operational Challenges**: Same-store SHOP NOI down 2.2% YoY due to occupancy drop and nonrecurring costs.
- **Competitive Edge**: No financing contingency allows 8%+ pipeline yields vs. peers.

**【CEO Summary Section】**
- **SHOP Portfolio Growth**: Consolidated SHOP NOI grew 63% YoY, driven by 7 property transitions and a $74.3M acquisition. SHOP NOI is expected to double to 20% of total NOI by 2026.
- **Guidance Update**: Raised 2025 FFO per share guidance to 10%+ growth at midpoint, the strongest since 2014. Includes $75M in new investments at 8% yield.
- **Balance Sheet Strength**: Net debt/EBITDA at 3.6x (below target range), $1B liquidity, and $350M 5.35% bonds issued.
- **NHC Lease Update**: NHC renewed master lease for 2027-2032, but legality under default provisions is under review.

**【CIO Summary Section】**
- **Transition Results**: 7 properties transitioned to SHOP, with Q3 NOI exceeding prior rent by $3.7M. First acquisition (4 properties) yields 8.2% NOI.
- **Pipeline Activity**: $195M under LOI (8.4% yield), including 2026 targets for 20%+ SHOP NOI contribution.
- **Challenges**: Same-store SHOP NOI declined 2.2% YoY due to 110bps occupancy drop, $0.2M nonrecurring costs, and 15 units offline. Expect 2026 recovery to double-digit growth.

**【CFO Financial Commentary】**
- **Q3 Results**: Net income $0.69 (6.2% YoY), NAREIT FFO $1.09 (5.8% YoY), Normalized FFO $1.32 (28% YoY). FAD up 26% to $62.2M.
- **SHOP Impact**: Recognized $4.6M cash rent, $1.4M noncash rent, and $2M SHOP NOI. Loan payoffs added $2M to net income.
- **Liquidity**: $81.6M cash, $600M revolver, and $90.6M forward equity. Extended $125M term loan maturity to June 2026.

**【Q&A Highlights】**
- **NHC Negotiations**: NHC's renewal notice legality unclear; potential for arbitration over fair market rent.
- **Market Competition**: Increased REIT and private equity activity, but NHI's no financing contingency advantage drives pricing.
- **G&A Efficiency**: G&A at 0.56% of AUM (vs. peers), with $11M revenue per employee. Expect 60%+ SHOP revenue growth in 2025.
- **Bickford Update**: 86.1% occupancy, 1.49x EBITDARM coverage. Deferral repayments to boost 2026 base rent.

National Health Investors, Inc. (NHI) Q3 2025 Earnings Call Transcript

- **SHOP Growth Acceleration**: 57% increase in annualized SHOP NOI from 7 property transitions, with 13%-16% 2025 NOI growth guidance.
- **Dividend Boost**: 2.2% increase, first since 2021, signaling confidence in cash flow stability.
- **Pipeline Strength**: $343 million pipeline (50% SHOP-focused), targeting double-digit NOI growth.
- **Financial Resilience**: 3.9x net debt/EBITDA, $760M liquidity, and 8.1% YoY FFO growth.
- **Operational Challenges**: Temporary occupancy dip due to leadership changes, resolved in near term.

**【CEO Summary Section】**
- Q2 2025 revenue exceeded expectations, driven by a 29.4% year-over-year increase in SHOP NOI to $3.8 million and a 57% boost in annualized SHOP NOI from 7 property transitions.
- Raised 2025 normalized FFO guidance to $4.80 per share (8.1% YoY growth) and announced a 2.2% dividend increase, the first in 4 years.
- Pipeline of $343 million in senior housing deals, with 50% focused on SHOP, targeting double-digit NOI growth.
- Balance sheet strength: net debt/EBITDA at 3.9x (below 4x-5x target), $760 million liquidity, and no secured debt.

**【CFO Financial Commentary】**
- Q2 net income per share: $0.79 (down 2.5% YoY); normalized FFO: $1.22 (up 3.4% YoY).
- FAD increased 8.1% to $56 million, driven by $5.9 million in new cash rents and $1.5 million gain from equity investments.
- SHOP margin expanded 241 bps to 26.9%, with RevPOR growth of 3.7% and 13%-16% full-year NOI guidance.
- Completed $161.5 million in investments YTD, utilizing $123.5 million in equity and $35.4 million in debt payoffs.

**【Q&A Highlights】**
- **Investment Pipeline**: Delays in closing deals were due to timing, not quality; $130 million in signed LOIs expected to close Q3-Q4.
- **Discovery Relationship**: 10 properties remain in SHOP partnership; focus on smaller, secondary market assets with Sinceri Senior Living.
- **Occupancy Softness**: Temporary due to leadership changes and higher-than-normal move-outs; expect normalization.
- **NHC Lease Negotiations**: Special Board committee engaged; NHC's corporate coverage improved to 4.16x, supporting rent reset discussions.

National Health Investors, Inc. (NHI) Q2 2025 Earnings Call Transcript

- **Q1 2025 Strong Start**: $174.9M in acquisitions and higher deferral payments drove FFO guidance raise to $4.71 (6.1% YoY growth).
- **SHOP Growth Pipeline**: $264M pipeline with focus on RIDEA conversions; 12%-15% NOI growth target maintained despite Q1 seasonality.
- **Financial Strength**: 4.1x net debt/EBITDA, $135M cash, and $155M new investments at 8.2% yield.
- **Risks & Opportunities**: NHC lease renewal uncertainty amid Medicaid cuts; accelerating deal flow highlights competitive capital access.


**【CEO Opening Remarks】**
- Q1 2025 revenue exceeded expectations, driven by $174.9M in acquisitions and higher-than-expected deferral payments. Normalized FFO guidance midpoint raised by $0.08 to $4.71, reflecting 6.1% YoY growth.
- Active pipeline of $264M in real estate and SHOP deals, with focus on accretive investments. Not pursuing a $1.2M portfolio due to lack of shareholder value alignment.
- SHOP NOI growth target remains 12%-15% YoY, with progress on converting six Discovery properties to RIDEA structure.

**【CFO Financial Highlights】**
- Q1 net income: $0.74 per share (4.2% YoY increase). Normalized FFO: $1.15 (2.7% YoY). FAD: $56M (9.9% YoY growth).
- Cash rent collections up $2.6M QoQ, driven by acquisitions and NHC percentage rent ($1.2M). Deferred rent repayments exceeded expectations ($1.4M unscheduled).
- 2025 guidance includes $155M in unidentified investments at 8.2% yield. Balance sheet strong: $135M cash, 4.1x net debt/EBITDA, $409M ATM capacity.

**【CIO Asset Management Update】**
- SHOP NOI: $3.1M (4.9% YoY). Resident fees up 5.2% due to 390bps occupancy improvement to 89.2%. Margin decline (22.1%) attributed to seasonal move-outs.
- SLM portfolio transition complete, with $2.5M partial loan repayment. Focus on new operators and NOI recovery.
- Need-driven operators (Bickford, others) showing coverage improvement (1.41x EBITDARM). SNF coverage at 3.06x, driven by NHC stability.

**【Key Q&A Insights】**
- **NHC Lease Renewal**: 2026 renewal process ongoing, with Medicaid cuts as key risk. Independent director committee and Blueprint Advisors evaluating fair value.
- **SHOP Seasonality**: Q1 NOI dip (4.9% YoY) due to winter move-outs, but April occupancy up 40bps. Incentives rolling off to drive RPU growth.
- **Market Activity**: Accelerating deal flow with $264M pipeline and 3x+ funnel. Selective approach to maintain accretion, with 8.2% yield on new investments.
- **Debt Management**: $60.1M debt retired; $200M term loan extended to Dec 2025. Monitoring bond market for 2025 issuance to support growth.


National Health Investors (NHI)-6 May 25-2025 Q1 Earnings call transcript

- **Record Investment Year**: 2024 saw $237.5 million in investments at 8.6% yield, with 2025 guidance of $225 million. 
- **SHOP Growth**: 12.5% Q4 NOI growth, 89.4% occupancy, and 60 bps RevPOR increase. 
- **Balance Sheet Strength**: 4.1x leverage, $425M ATM capacity, and $221.7M FAD guidance. 
- **Strategic Shift**: Transitioning triple-net assets to SHOP to capitalize on senior housing tailwinds. 
- **Deferred Rent Outlook**: $4 million expected in 2025 vs. $11 million in 2024.

**【CEO Summary Section】**
- The company reported strong fourth-quarter results, with cash rent increasing 9% year-over-year, driven by ramp-ups and deferral repayments. 
- SHOP NOI grew 12.5% YoY, with occupancy reaching 89.4% and RevPOR up 60 basis points. 
- 2024 was the most active investment year since 2019, with $237.5 million in investments at an 8.6% yield. 
- 2025 guidance includes $225 million in new investments and 12-15% SHOP NOI growth. 
- Management emphasized transitioning triple-net senior housing assets to SHOP structures to capitalize on industry tailwinds.

**【CFO Financial Commentary】**
- Full-year NAREIT FFO per share increased 3.6% to $4.05, with Q4 FFO up 13.8% to $1.24. 
- Normalized FFO rose 2.5% to $4.44, and FAD increased 8.7% to $204.2 million. 
- Balance sheet leverage improved to 4.1x, with $425 million in available ATM capacity. 
- 2025 guidance includes $221.7 million in FAD, a 8.6% increase over 2024. 
- Deferred rent collections totaled $11 million in 2024, with $4 million expected in 2025.

**【CIO Operational Highlights】**
- Fourth-quarter investments of $53.1 million at 9% yield, with $152.3 million in Board-approved deals and $190 million in pipeline. 
- SHOP margin improved 350 basis points in 2024, targeting 400 basis points over the long term. 
- SLM portfolio transition completed, with $9.7 million sale and $9.4 million financing at 8.5%. 
- Discovery Senior Living portfolio under evaluation, with potential rent step-up below 5% target yield.

**【Q&A Key Takeaways】**
- **SLM Portfolio**: 2024 rent and interest income expected to decline 30% in 2025, with mezzanine loan recovery TBD. 
- **SHOP Expansion**: Targeting 5-10% portfolio exposure by end-2025, with focus on triple-net to SHOP conversions. 
- **Investment Pipeline**: $340 million in LOIs and pipeline, with confidence to exceed 2024 investment total. 
- **CapEx**: $10 million annualized for SHOP repositioning, supporting RevPOR growth. 
- **Policy Impact**: Skilled nursing market remains robust despite Medicaid budget uncertainty.

National Health Investors (NHI)-26 Feb 25-2024 Q4 Earnings call transcript

National Health Investors (NHI)-6 Nov 24-2024 Q3 Earnings call transcript

National Health Investors (NHI)-7 Aug 24-2024 Q2 Earnings call transcript

National Health Investors (NHI)-7 May 24-2024 Q1 Earnings call transcript

National Health Investors (NHI)-21 Feb 24-2023 Q4 Earnings call transcript

National Health Investors (NHI)-8 Nov 23-2023 Q3 Earnings call transcript

National Health Investors (NHI)-9 Aug 23-2023 Q2 Earnings call transcript

- **Q1 Strong Performance**: 98.4% cash collections, $54.8M investments, and 31% YoY EBITDARM coverage improvement.
- **SHOP Challenges**: 2023 recovery delayed to 2024; 2023 focus on incremental margin improvement.
- **Financial Strength**: 4.6x leverage, $500M+ liquidity, and FAD payout ratio of 81.8%.
- **Bickford Progress**: Occupancy momentum building; pro forma coverage 1.39x vs. reported 1.26x.
- **Guidance Update**: Normalized FFO raised to $4.37-$4.42, driven by reduced stock comp and deferral collections.

**【CEO Opening Remarks】**
- Q1 2023 results exceeded expectations, driven by 98.4% cash collections and limited rent concessions.
- $54.8 million in new investments, including $2.5 million utilized from Bickford deferrals.
- Portfolio optimization continues with 5 property sales YTD, targeting low NOI yield assets.
- EBITDARM coverage for need-driven senior housing improved 31% YoY to 1.11x, highest since Q1 2020.
- SHOP portfolio (3% of NOI) underperformed, with margin decline to 16.2%, but long-term upside remains.

**【CFO Financial Commentary】**
- Q1 GAAP net income: $0.79, NAREIT FFO: $1.16, Normalized FFO: $1.11 per share.
- FAD: $47.7 million, with $1.3 million in discrete items boosting performance.
- Updated full-year guidance: Normalized FFO range raised to $4.37-$4.42 (from $4.24-$4.30) due to reduced stock comp and deferral collections.
- Leverage ratio improved to 4.6x, with $500+ million liquidity.
- Next debt maturities: $220M term loan (Sept 2023), $50M private placement (Nov 2023).

**【Kevin Pascoe - Asset Management】**
- Senior housing occupancy improved 400bps YoY to 81.3%, driven by Bickford (81.3% vs. market 80.4%) and entrance fee communities.
- SNF portfolio coverage at 2.48x, up 2.4% QoQ, supported by NHC and Ensign operators.
- SHOP portfolio repositioning delayed due to operator changes and CapEx delays, but 2024 recovery expected.
- 7 properties held for sale ($21M net book value), with majority expected to close in Q2-Q3.

**【Q&A Highlights】**
- **SHOP Recovery Timing**: Pushed to 2024 due to operator transitions and delayed CapEx; 2023 focus on incremental improvement.
- **Bickford Occupancy**: March occupancy uptick, with lead/tour volumes increasing; pro forma coverage 1.39x vs. reported 1.26x.
- **Guidance Changes**: $3.4M reduction in stock comp and deferral collections drove FFO increase; SHOP NOI contribution lowered.
- **Disposition Strategy**: Patient approach to selling low-yield assets; 2 pulled from held-for-sale due to financing challenges.


Actual												1.37	0.99	0.95	0.83	0.78	0.85	0.67	0.14	0.18	0.47	0.78	0.04	0.79	0.92	0.68	0.74	0.71	0.81	0.65	0.95	0.74	0.79	0.69
Forecast												0.955	1.005	0.895	1.0133	0.89	0.89	0.865	0.925	0.63	0.73	0.77	0.83	0.66	0.69	0.72	0.6807	0.6778	0.7233	0.7309	0.74	0.7296	0.7487	0.6843
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+43.46%	-1.49%	+6.15%	-18.09%	-12.36%	-4.49%	-22.54%	-84.86%	-71.43%	-35.62%	+1.30%	-95.18%	+19.70%	+33.33%	-5.56%	+8.71%	+4.75%	+11.99%	-11.07%	+28.38%	+1.43%	+5.52%	+0.83%

Actual	--	--	--	--	--	--	--	--	--	--	--	76.53M	77.92M	77.82M	74.94M	74.75M	68.35M	67.04M	69.67M	64.56M	40.00M	59.39M	53.76M	65.30M	60.95M	62.26M	60.72M	62.19M	65.76M	63.32M	65.78M	68.87M	70.27M	62.18M
Forecast	--	--	--	--	--	--	--	--	--	--	--	75.84M	76.96M	75.04M	77.60M	78.01M	71.59M	68.95M	65.60M	70.78M	65.74M	62.49M	61.04M	61.86M	58.86M	62.58M	64.21M	64.93M	64.95M	67.93M	68.15M	66.79M	68.34M	67.32M
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+0.90%	+1.24%	+3.70%	-3.43%	-4.18%	-4.53%	-2.76%	+6.20%	-8.79%	-39.16%	-4.95%	-11.91%	+5.56%	+3.56%	-0.52%	-5.43%	-4.23%	+1.25%	-6.79%	-3.48%	+3.11%	+2.83%	-7.64%

NHI

NHI fundamentals

NHI Q3 2025 Earnings

Earnings Call

You can ask Aime

NHI

NHI fundamentals

NHI Q3 2025 Earnings

Earnings Call

NHI Earnings Call Summary for Q3/202510:00 AM on Nov 7, 2025

NHI Earnings Call Summary for Q2/202510:00 AM on Aug 7, 2025

NHI Earnings Call Summary for Q1/202510:00 AM on May 6, 2025

NHI Earnings Call Summary for Q4/202411:00 AM on Feb 26, 2025

NHI Earnings Call Summary for Q3/202411:00 AM on Nov 6, 2024

You can ask Aime